2301 - 2325 of 6557 Results
Title
Year
- Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset2026OPENTitle: Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onsetJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 51End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-026-01265-3Best OA location URL: https://www.nature.com/articles/s41531-026-01265-3_reference.pdfCitation Count: 0
- Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acid2015OPENTitle: Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acidJournal Name: Journal of NeurochemistryPublisher: WileyVol: 133Issue #: 6Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13074Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13074Citation Count: 63
-
OPENTitle: Music to move persons with Parkinson’s disease: a personalized approachJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 1Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10615-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10615-5.pdfCitation Count: 5
-
OPENTitle: The “Michael Foundation”—A foundation against epilepsyJournal Name: EpilepsiaPublisher: WileyVol: 55Issue #: 6Start Page: 803End Page: 805Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/epi.12509Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12509Citation Count: 0
-
OPENTitle: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.041115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.041115Citation Count: 0
- Disease-modifying therapies for Parkinson's disease2013OPENTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page: e1003178End Page: e1003178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
-
OPENTitle: The G2019S LRRK2 mutation exacerbates α-synuclein and tau neuropathology through divergent pathways in Parkinson’s disease modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 150Issue #: 1Start Page: 51End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1007/s00401-025-02956-6Best OA location URL: https://doi.org/10.1007/s00401-025-02956-6Citation Count: 1
-
OPENTitle: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein DestabilizationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 8Start Page: 5273End Page: 5286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-018-1449-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-018-1449-2.pdfCitation Count: 19
-
OPENTitle: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cellsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 12Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.038596Best OA location URL: https://doi.org/10.1242/dmm.038596Citation Count: 74
-
OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 33
-
OPENTitle: Combating Parkinson’s disease-associated toxicity by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 114Issue #: 5Start Page: 803End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1620082114Best OA location URL: https://www.pnas.org/content/pnas/114/5/803.full.pdfCitation Count: 6
-
OPENTitle: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patientsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abg3092Best OA location URL: https://doi.org/10.1126/sciadv.abg3092Citation Count: 112
-
OPENTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Best OA location URL: https://doaj.org/article/33431349c85d454db7ad2af33222a015Citation Count: 0
-
OPENTitle: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3116End Page: 3128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz260Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3116/30063806/awz260.pdfCitation Count: 98
-
OPENTitle: Disease-related patterns of in vivo pathology in Corticobasal syndromeJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 45Issue #: 13Start Page: 2413End Page: 2425Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s00259-018-4104-2Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/9fe6a2c3-b627-4290-99fe-c31eb72bafcbCitation Count: 31
-
OPENTitle: Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 7Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/alz.12083Best OA location URL: https://doi.org/10.1002/alz.12083Citation Count: 69
-
OPENTitle: Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson’s diseaseJournal Name: Molecular Systems BiologyPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 712End Page: 737Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s44320-026-00190-0Best OA location URL: https://link.springer.com/content/pdf/10.1038/s44320-026-00190-0.pdfCitation Count: 2
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 12Start Page: 2688End Page: 2699Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 5
-
OPENTitle: fMRI-based deep brain stimulation programming for Parkinson's disease: a blinded, crossover clinical trialJournal Name: Brain StimulationPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 103069End Page: 103069Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2026.103069Best OA location URL: https://www.brainstimjrnl.com/article/S1935-861X(26)00046-X/pdfCitation Count: 1
-
OPENTitle: RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathwayJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 11Start Page: eaav0443End Page: eaav0443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.aav0443Best OA location URL: https://advances.sciencemag.org/content/advances/4/11/eaav0443.full.pdfCitation Count: 216
-
OPENTitle: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stressJournal Name: Redox BiologyPublisher: Elsevier BVVol: 19Issue #:Start Page: 62End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021Best OA location URL: https://doi.org/10.1016/j.redox.2018.07.021Citation Count: 93
-
OPENTitle: The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathiesJournal Name: Clinical GeneticsPublisher: WileyVol: 94Issue #: 3-4Start Page: 339End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/cge.13405Best OA location URL: https://zenodo.org/record/3911322Citation Count: 13
-
OPENTitle: Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammationJournal Name: GliaPublisher: WileyVol: 66Issue #: 11Start Page: 2427End Page: 2437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/glia.23482Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6275110Citation Count: 57
-
OPENTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 36